What's in the literature?

Research output: Contribution to journalReview article

Abstract

Once again, the field of neuromuscular diseases has produced a wide-ranging and interesting group of papers, a small number of which are highlighted. Many papers focus on treatments, and although these are generally symptomatic rather than curative, they provide clinicians with guidelines for providing patients with relief from neuropathic pain, muscle cramps, myotonia, and the weakness associated with limb-girdle muscular dystrophy. For peripheral neuropathies, additional treatment aspects and a possible mechanism for neuroprotection during chemotherapy are also addressed. The clinical features and genetics of hereditary spastic paraplegia and of motor neuron disease are explored with particular emphasis on the heterogeneity of clinical presentations that may arise from genetic mutations. Myasthenia gravis receives some well-deserved attention, particularly with regard to treatment as well as diagnosis.

Original languageEnglish (US)
Pages (from-to)223-228
Number of pages6
JournalJournal of Clinical Neuromuscular Disease
Volume11
Issue number4
DOIs
StatePublished - Jun 1 2010

Fingerprint

Hereditary Spastic Paraplegia
Limb-Girdle Muscular Dystrophies
Myotonia
Muscle Cramp
Neuromuscular Diseases
Motor Neuron Disease
Myasthenia Gravis
Neuralgia
Peripheral Nervous System Diseases
Therapeutics
Guidelines
Drug Therapy
Mutation
Neuroprotection

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{75c34bfc02cd47f3857affb0fd2c9588,
title = "What's in the literature?",
abstract = "Once again, the field of neuromuscular diseases has produced a wide-ranging and interesting group of papers, a small number of which are highlighted. Many papers focus on treatments, and although these are generally symptomatic rather than curative, they provide clinicians with guidelines for providing patients with relief from neuropathic pain, muscle cramps, myotonia, and the weakness associated with limb-girdle muscular dystrophy. For peripheral neuropathies, additional treatment aspects and a possible mechanism for neuroprotection during chemotherapy are also addressed. The clinical features and genetics of hereditary spastic paraplegia and of motor neuron disease are explored with particular emphasis on the heterogeneity of clinical presentations that may arise from genetic mutations. Myasthenia gravis receives some well-deserved attention, particularly with regard to treatment as well as diagnosis.",
author = "Zachary Simmons",
year = "2010",
month = "6",
day = "1",
doi = "10.1097/CND.0b013e3181e1f058",
language = "English (US)",
volume = "11",
pages = "223--228",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

What's in the literature? / Simmons, Zachary.

In: Journal of Clinical Neuromuscular Disease, Vol. 11, No. 4, 01.06.2010, p. 223-228.

Research output: Contribution to journalReview article

TY - JOUR

T1 - What's in the literature?

AU - Simmons, Zachary

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Once again, the field of neuromuscular diseases has produced a wide-ranging and interesting group of papers, a small number of which are highlighted. Many papers focus on treatments, and although these are generally symptomatic rather than curative, they provide clinicians with guidelines for providing patients with relief from neuropathic pain, muscle cramps, myotonia, and the weakness associated with limb-girdle muscular dystrophy. For peripheral neuropathies, additional treatment aspects and a possible mechanism for neuroprotection during chemotherapy are also addressed. The clinical features and genetics of hereditary spastic paraplegia and of motor neuron disease are explored with particular emphasis on the heterogeneity of clinical presentations that may arise from genetic mutations. Myasthenia gravis receives some well-deserved attention, particularly with regard to treatment as well as diagnosis.

AB - Once again, the field of neuromuscular diseases has produced a wide-ranging and interesting group of papers, a small number of which are highlighted. Many papers focus on treatments, and although these are generally symptomatic rather than curative, they provide clinicians with guidelines for providing patients with relief from neuropathic pain, muscle cramps, myotonia, and the weakness associated with limb-girdle muscular dystrophy. For peripheral neuropathies, additional treatment aspects and a possible mechanism for neuroprotection during chemotherapy are also addressed. The clinical features and genetics of hereditary spastic paraplegia and of motor neuron disease are explored with particular emphasis on the heterogeneity of clinical presentations that may arise from genetic mutations. Myasthenia gravis receives some well-deserved attention, particularly with regard to treatment as well as diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=77953253065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953253065&partnerID=8YFLogxK

U2 - 10.1097/CND.0b013e3181e1f058

DO - 10.1097/CND.0b013e3181e1f058

M3 - Review article

AN - SCOPUS:77953253065

VL - 11

SP - 223

EP - 228

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 4

ER -